Cargando…

Clofazimine: A potential therapeutic option for severe COVID-19

Detalles Bibliográficos
Autor principal:	Ateya, Areej Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2021
Materias:	Letter to Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880843/ https://www.ncbi.nlm.nih.gov/pubmed/33735762 http://dx.doi.org/10.1016/j.mehy.2021.110535

Ejemplares similares

Zinc supplementation for males during COVID-19: Is it beneficial?
por: Ateya, Areej Mohamed, et al.
Publicado: (2021)

Clofazimine induced methemoglobinemia – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro
por: Zhang, Shuo, et al.
Publicado: (2017)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

COVID-19 therapeutic options for patients with kidney disease
por: Izzedine, Hassan, et al.
Publicado: (2020)

Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient
por: Barot, Rakesh K, et al.
Publicado: (2011)

Colchicine as a possible therapeutic option in COVID-19 infection
por: Parra-Medina, Rafael, et al.
Publicado: (2020)

Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
por: Delafosse, Marion, et al.
Publicado: (2020)

The looming pandemic of COVID-19: What therapeutic options do we have now?
por: Afsar, Nasir Ali
Publicado: (2020)

Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
por: Brogi, Simone, et al.
Publicado: (2020)

Is Sildenafil a Therapeutic Option for Noncompaction?
por: Finsterer, Josef, et al.
Publicado: (2014)

Hemodynamic Monitoring Options in COVID-19
por: Rozental, Olga, et al.
Publicado: (2020)

Clofazimine for the treatment of tuberculosis
por: Stadler, Jacob A. M., et al.
Publicado: (2023)

Stem cells as an option for the treatment of COVID-19
por: Cuevas-González, Maria Veronica, et al.
Publicado: (2022)

Diagnostic options for coronavirus disease 2019 (COVID-19)
por: Xiao, Yuanyuan, et al.
Publicado: (2020)

Clofazimine-induced Hair Pigmentation
por: Philip, Mariam, et al.
Publicado: (2012)

The Role of Radiotherapy Among the Therapeutic Options for Castleman’s Disease
por: Karaca, Feryal, et al.
Publicado: (2014)

Interleukin-17: A potential therapeutic target in COVID-19
por: Mendoza, Vicky M. Montaño
Publicado: (2020)

Diversifying online rheumatology education options in the era of COVID-19
por: Ahmed, Sakir, et al.
Publicado: (2020)

Is teicoplanin a complementary treatment option for COVID-19? The question remains
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Potential Therapeutic Effects of Virgin Coconut Oil on COVID-19
por: Ghorbannezhad, Ghazaleh, et al.
Publicado: (2022)

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19
por: Esam, Zohreh
Publicado: (2020)

Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study
por: Zweijpfenning, Sanne M.H., et al.
Publicado: (2021)

Mechanistic basis and therapeutic relevance of hypocalcemia during severe COVID-19 infection
por: Singh, Vijay P., et al.
Publicado: (2020)

The potential indicators for pulmonary fibrosis in survivors of severe COVID-19
por: Huang, Wenhui, et al.
Publicado: (2021)

Potential Therapeutic Options for COVID-19
por: Zheng, Xiaoqin, et al.
Publicado: (2020)

Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report
por: Streicher, Caroline, et al.
Publicado: (2020)

Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid
por: Unal, Gokhan, et al.
Publicado: (2020)

Therapeutic potential of N-acetyl cysteine during COVID-19 epoch
por: Kapur, Ajita, et al.
Publicado: (2022)

Lactulose: an effective preventive and therapeutic option for ischemic stroke by production of hydrogen
por: Chen, Xiao, et al.
Publicado: (2012)

Treating mitochondrial disorders requires full exploitation of available therapeutic options
por: Finsterer, Josef, et al.
Publicado: (2017)

Clofazimine for Rapidly Growing Mycobacterial Infections
por: Carey, George B, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022)

Clofazimine induced pigmentation in leprosy patches
por: Chavhan, Samiksha Deepak, et al.
Publicado: (2022)

Extemporaneously compounded liquid formulations of clofazimine
por: Taneja, R., et al.
Publicado: (2023)

Right Ventricular Ablation as a Therapeutic Option for Left Ventricular Hypertrabeculation / Noncompaction
por: Finsterer, Josef, et al.
Publicado: (2014)

Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter]
por: Shuja, Syed Hasan, et al.
Publicado: (2021)

Topical finasteride: A potential therapeutic option for hidradenitis suppurativa
por: Manfredini, Marco, et al.
Publicado: (2022)

Potential Biomarkers for Defining the Severity, Progression, and Survival from COVID-19
por: Okechukwu, Chidiebere Emmanuel
Publicado: (2021)

Therapeutic potential for clomiphene, a selective estrogen receptor modulator, in the treatment of COVID‐19
por: Ghasemnejad-Berenji, Morteza, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ktr04rk4ouhj8j8tehq85nvk06